Clinical trial
Phase I Study of SPH1188-11 in NSCLC
NCT03231475
Study timeline
Study start (actual)2017-07-21Date precision: day
Registry last updated2021-11-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
NSCLC Stage IIIBunresolved
NSCLC Stage IVunresolved
Interventions
SPH1188-11DRUG
Sponsors & collaborators
Shanghai Pharmaceuticals Holding Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03231475 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.